Last news
Eyebright Medical Published its 2024 Environmental, Social and Governance Report

Eyebright Medical Published its 2024 Environmental, Social and Governance Report

Commitment to Sustainable Development, Social Responsibility, and Corporate Governance HONG KONG, April 23, 2025 /PRNewswire/ -- Eyebright Medical Technology (Beijing) Co., Ltd. ("Eyebright Medical", the "Company", Stock Code: 688050.SH, together...

Pulxion and Medtronic Partner to Advance Innovative Health Solutions

Pulxion and Medtronic Partner to Advance Innovative Health Solutions

TAIPEI, April 23, 2025 /PRNewswire/ -- According to statistics published by the World Health Organization (WHO) in 2025, cardiovascular diseases (CVDs) are the leading cause of death globally, claiming approximately 18 million lives annually and...

Trip.com Group Witnesses Double-digit Cross-border Growth for May Labour Day Holiday

Trip.com Group Witnesses Double-digit Cross-border Growth for May Labour Day Holiday

Trips to two or more cities increase by 60% compared to last year Triple-digit growth in alternative stays – popular among travellers in South Korea, Hong Kong SAR and Thailand Strong cross-border travel from China, Japan, South Korea and Vietnam...

Cohesity Automation Provides Faster, More Comprehensive Cyber Incident Response

Cohesity Automation Provides Faster, More Comprehensive Cyber Incident Response

Cohesity RecoveryAgent's AI-powered Orchestration Makes Cyber Response and Recovery Easy so Customers Can Recover From Incidents Faster and With More Confidence SINGAPORE, April 23, 2025 /PRNewswire/ -- Cohesity, the leader in AI-powered data...

Investment of Approx. USD 4.5 Million in Development of Diagnostics for Tuberculosis to Partners Including Fujirebio and University Hospital Heidelberg

Investment of Approx. USD 4.5 Million in Development of Diagnostics for Tuberculosis to Partners Including Fujirebio and University Hospital Heidelberg

TOKYO, April 23, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 679 million (USD 4.5 million1) for the development of diagnostics for tuberculosis, in addition to an...

NEC Asia Pacific Achieves ISO 14001 Certification in Singapore, Reinforcing Commitment to Environmental Sustainability

NEC Asia Pacific Achieves ISO 14001 Certification in Singapore, Reinforcing Commitment to Environmental Sustainability

SINGAPORE, April 23, 2025 /PRNewswire/ -- NEC Asia Pacific (NEC APAC), the ASEAN regional headquarters of global technology firm NEC Corporation, has successfully achieved ISO 14001:2015 certification, demonstrating its steadfast commitment to...

VARON Advocates for Sustainability on Earth Day with Eco-Friendly Oxygen Solutions

VARON Advocates for Sustainability on Earth Day with Eco-Friendly Oxygen Solutions

NEW YORK, April 23, 2025 /PRNewswire/ -- This Earth Day, VARON is proud to reaffirm its commitment to both respiratory health and environmental responsibility. As a global leader in oxygen concentrator technology, VARON continues to advance...

Ascletis Announces Positive Topline Results of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Submission of 13-week Phase IIa Study Protocol to FDA

Ascletis Announces Positive Topline Results of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Submission of 13-week Phase IIa Study Protocol to FDA

- ASC30 oral once-daily tablet demonstrated a 6.5% placebo-adjusted mean body weight reduction from baseline after four-week treatment using weekly doses with titrations of 2 mg, 10 mg, 20 mg , and 40 mg doses. - ASC30 oral once-daily tablet also...

1 ... 275 276 277 278 279 280 281 282 283 ... 2608
menu
menu